WHO backs wider use of weight-loss medicines, calling obesity a chronic disease
The guidance focuses on GLP-1 therapies – medicines such as liraglutide, semaglutide and tirzepatide – and offers conditional recommendations on…
Newscenter UK
The guidance focuses on GLP-1 therapies – medicines such as liraglutide, semaglutide and tirzepatide – and offers conditional recommendations on…
More than 230,000 families – that’s around 1.15 million people – received monthly food parcels between 1 and 27 November,…
“Promise that you will take your medicines lifelong,” Ms. Mishra told UN News in a message marking World AIDS Day…
Access Denied You don’t have permission to access ” on this server. Reference #18.e4e22517.1764630361.4efed358 Source
Access Denied You don’t have permission to access ” on this server. Reference #18.e4e22517.1764590535.4a5c2b39 Source
Access Denied You don’t have permission to access ” on this server. Reference #18.be7a7b5c.1764586571.3646280f Source
Access Denied You don’t have permission to access ” on this server. Reference #18.be7a7b5c.1764588713.366f78c9 Source
Access Denied You don’t have permission to access ” on this server. Reference #18.e4e22517.1764592451.4a81b48a Source
Access Denied You don’t have permission to access ” on this server. Reference #18.cab31402.1764594422.b47a641e Source
Access Denied You don’t have permission to access ” on this server. Reference #18.be7a7b5c.1764609631.380c3344 Source